Inside a drug den in Barcelona's Raval after a record-time eviction
Neighbors report a rise in drug flats, while city council says numbers have fallen from 100 to 10 in seven years
drugs
Hashish trafficking booms in Catalonia: 14.6 tonnes seized in 2023
Drug-related arrests are also on the rise, with nearly a thousand per year
Almost 600,000 cannabis plants seized in 2022
Over 2,100 arrests related to dealing of drug last year in Catalonia, 6% up on 2021
Twenty nightclubs to give out lids for glasses to combat drink spiking
Clubs to implement 'Ask for Angela' international safety codeword system
Anti-drug raids in Barcelona lead to scores of arrests
51 detained in major police operation against cocaine and heroin trafficking
Beloved priest Pare Manel dies after a life dedicated to marginal neighborhoods and inmates
His legacy includes a foundation that works with youth and families in vulnerable situations in Barcelona
Operation against drug and weapon traffickers continues with more raids
Catalan police enter homes north of Barcelona a day after some 40 people were arrested
Barcelona, the capital of cocaine
International study of wastewater in 37 countries puts Catalan city among those with most illicit drug use
'Very serious blow' to drug trafficking explained
54 arrests, and large amounts of heroin, cocaine, ecstasy, weapons and money confiscated
Major police operation against drug trafficking network in central Barcelona
More than 500 police officers take part in raids in Raval neighborhood against organization distributing illegal drugs and arrest 54
Police dismantle Catalonia's 'largest ever drug flat network'
New details emerge as Mossos d'Esquadra explain how two-year operation led to 58 arrests, including four gang leaders
,
Mayor praises 'blow' to drug traffickers after major police operation
Ada Colau and home affairs minister recognize police work as more than 50 people are arrested in narcoflats
Catalan pharmaceutical giant Grifols sees a 23% jump in net profit in the first half of 2014
During the first half of the year, the revenues of the Catalan multinational pharmaceutical company Grifols rose by 16.7% to €1.61 bilion, 75% of which came from the Bioscience division and 18% from Diagnostic. Compared to the first quarter, the proportion of total sales generated by each of the group’s divisions remains unchanged after the acquisition of Novartis' diagnostic business. The world´s third-largest blood-derivate product maker, Grifols obtained a net profit of €224.8 million, 23% more compared with the same period last year, as reported by the company to the Spanish Stock Exchange Authority (CNMV). These positive figures were achieved due to the maintenance of financial costs, made possible by improved financial conditions, despite having increased debt in absolute terms.